Cardiac Biomarkers and Geriatric Assessment in Metastatic Castrate-Resistant Prostate Cancer During Abiraterone Acetate Therapy – A Cardio-Oncology Study

BACKGROUND: Abiraterone acetate (AA) is a drug used in advanced prostate cancer. However, known clinical factors with predictive and prognostic value are scarce. This study evaluated cardiovascular (CV) factors and geriatric scales as potential markers of superior response during AA therapy. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilk, Michał, Waśko-Grabowska, Anna, Skoneczna, Iwona, Szczylik, Cezary, Szmit, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716601/
https://www.ncbi.nlm.nih.gov/pubmed/36447439
http://dx.doi.org/10.1177/10732748221140696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716601/
https://www.ncbi.nlm.nih.gov/pubmed/36447439
http://dx.doi.org/10.1177/10732748221140696

Ejemplares similares